STUART LANKFORD: Open Payments
NPI 1053833343 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 16 payments from 8 companies in 2025. Trend: 2023 $156 · 2024 $73 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Calliditas Therapeutics US Inc. | 2 | $45 |
| Pharmacosmos Therapeutics Inc. | 2 | $35 |
| Amgen Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $16 |
Products named: ACTHAR, JYNARQUE, FARXIGA, TARPEYO, MONOFERRIC, KRYSTEXXA, IBSRELA, JARDIANCE.
Industry payments across IL — which companies pay providers there.
